Société Applied Genetic Technologies Corporation
Actions
AGTC
US03820J1007
Recherche biotechnologique et médicale
Métier
Nombre d'employés: 102
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Fellows
CEO | Chief Executive Officer | 67 | 01/11/22 |
David Jacobs
CTO | Chief Tech/Sci/R&D Officer | - | 08/06/22 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/12/22 |
Abraham Scaria
CTO | Chief Tech/Sci/R&D Officer | - | 15/11/21 |
Ashwin Datt
BRD | Director/Board Member | - | 01/12/22 |
Chris Hollowood
BRD | Director/Board Member | 50 | 01/12/22 |
Hope D'Oyley-Gay
LAW | General Counsel | - | 11/11/21 |
Gerald Reynolds
TRE | Treasurer | - | 01/03/20 |
Janet Rae
LAW | General Counsel | - | 18/06/21 |
Matthew Feinsod
PRN | Corporate Officer/Principal | - | 01/07/14 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
David Fellows
CEO | Chief Executive Officer | 67 | 01/11/22 |
Chris Hollowood
BRD | Director/Board Member | 50 | 01/12/22 |
Ashwin Datt
BRD | Director/Board Member | - | 01/12/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 67 686 195 | 67 316 723 ( 99,45 %) | 54 000 ( 0,0798 %) | 99,45 % |
Coordonnées société
Beacon Therapeutics (USA), Inc.
14193 NW 119th Terrace Suite 10
32615, Alachua
+386 462 2204
http://agtc.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
-2,31 % | 103 Md | |
+0,56 % | 95,28 Md | |
+0,55 % | 22,15 Md | |
-17,37 % | 21,02 Md | |
-8,65 % | 18,15 Md | |
-41,01 % | 16,73 Md | |
-14,85 % | 16,05 Md | |
+3,21 % | 13,68 Md | |
+33,54 % | 12,17 Md |